| 5/22/26 |
Roche (RO) |
giredestrant for Breast Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 5/22/26 |
Roche (RO) |
giredestrant for HR+/HER2- Breast Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 5/21/26 |
Eli Lilly and Company (LLY) |
retatrutide for Obesity |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 5/21/26 |
Cogent Biosciences (COGT) |
bezuclastinib for Gastrointestinal Stromal Tumor (GIST) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 5/21/26 |
AstraZeneca (AZN) |
puxitatug samrotecan for Ovarian Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |